ArticleNature communications2026
Immune surveillance on the insect body surface recognizes a pathogen-derived fungal protease to activate defenses.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune systems must distinguish between pathogens and commensals to mount effective responses. However, how hosts discriminate among fungi at surface barriers is largely unknown. Here, we report a surveillance mechanism on the locust body surface that couples general fungal recognition with pathogen-specific activation. The host immulectin-1 (IML1) binds surface-exposed fungal mannans, but immune activation requires cleavage by fungal protease SP28 to release bioactive peptide. The protease is found in most fungi, but high evolutionary divergence confers its host-specific activity. Disrupting the IML1-SP28 interaction, either by deleting fungal SP28, silencing host IML1, or blocking IML1 with excess mannan, abrogates immune responses and accelerates host mortality. This protease-gated checkpoint suggests an evolutionarily conserved principle in insect-fungal interactions, with potential implications for developing novel biopesticides and antifungal agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.